Overview

Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet

Corporate Profile
Headquartered in Lawrence, Massachusetts, NxStage Medical, Inc. is a medical device company that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, acute kidney failure and fluid overload.
Investor Kit
Title
Investor Fact Sheet
Download Documentation
2008 Annual Report/Form 10-K
Download Documentation
2009 Proxy Statement
Download Documentation
Recent NewsMore News >>
DateTitle 
03/08/10NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome
LAWRENCE, Mass. and SEATTLE, March 8, 2010 /PRNewswire via COMTEX/ -- Booths # 23-25 at the Annual Dialysis Conference -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study, which show the significant improvement of overall sleep quality and marked improvement in Restless Legs Syndrome (RLS) experienced by patients after four months of daily home hemodialysis therapy with the NxSt... 
Printer Friendly Version
03/02/10NxStage(R) and Dirinco Sign Distribution Agreement For System One(TM) in the Netherlands
LAWRENCE, Mass., March 2, 2010 /PRNewswire via COMTEX/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it signed a five-year distribution agreement with Dirinco, an independent company, for the promotion, sale, delivery and service of certain NxStage and Medisystems products in the Netherlands. Under the terms of the agreement, the NxStage System One and PureFlow(TM) SL dialysate preparation system will be available to dialy... 
Printer Friendly Version
02/25/10NxStage Reports Fourth Quarter and Full-Year 2009 Financial Results That Exceed Company Guidance
Highlights: -- Full-Year Revenue Increases to $148.7 million, 15% Annual Growth -- Full-Year Home Revenue Increases to $63.5 million, 31% Annual Growth -- Q4 Gross Margin Improves to 28%, Up 300 bps Sequentially -- 2010 Outlook Signals Continuing Momentum in Home Market and Improved Cash Flow LAWRENCE, Mass., Feb 25, 2010 /PRNewswire via COMTEX/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported financial results for the three ... 
Printer Friendly Version
02/23/10NxStage(R) Announces New Vice President and General Manager, Critical Care Therapies
LAWRENCE, Mass., Feb 23, 2010 /PRNewswire via COMTEX/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Elise A. Tordella has joined the Company as Vice President and General Manager of Critical Care Therapies. In this position, Ms. Tordella will oversee NxStage's strategic growth initiatives to provide quality continuous renal replacement therapy (CRRT) solutions to the estimated U.S. $100 million critical care market opportuni... 
Printer Friendly Version
Company Calendar
March 2010?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-1123
03/03/10
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
45
03/05/10
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
8-K
Formats:  Excel HTML Adobe PDF Word
6
78910
03/10/10
4
Formats:  HTML Adobe PDF Word
111213
14151617181920
21222324252627
28293031515253
Stock Quote
NXTM (Common Stock)
ExchangeNASDAQ
Price$10.34
Change Stock is Up 0.21 (2.07%)
Volume189,222
As of 03/10/10
4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Transfer Agent
Computershare
Shareholder Services, Inc.
250 Royall Street
Canton, MA 02021
Tel: 781-575-2000
Website: computershare.com
Receive E-mail AlertsE-mail Alert Icon
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Stock Quote Disclaimer
This data is provided as a convenience for stockholders and is for informational purposes only. This data is not intended, and should not be relied upon, for trading purposes. Neither the Company nor its data providers guarantee the accuracy or completeness of any stock price or other data displayed, nor shall any such party be liable in any way to the user of the data or to any other person for any delays, inaccuracies, errors in, or omission of any such data or the transmission thereof, or for any actions taken in reliance thereon or for any damages arising therefrom or occasioned thereby. Investors are reminded that historical and current stock price performance data are not necessarily indicative of future performance.